Joseph Mashni

919 total citations
17 papers, 309 citations indexed

About

Joseph Mashni is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Joseph Mashni has authored 17 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Joseph Mashni's work include Renal cell carcinoma treatment (7 papers), Renal and related cancers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Joseph Mashni is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Renal and related cancers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Joseph Mashni collaborates with scholars based in United States, France and Canada. Joseph Mashni's co-authors include Paul Russo, John E. Musser, Daniel D. Sjoberg, Jonathan Coleman, Melissa Assel, Jeremy C. Durack, Stephen B. Solomon, Govindarajan Srimathveeravalli, Katie S. Murray and Behfar Ehdaie and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Urology.

In The Last Decade

Joseph Mashni

17 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Mashni United States 9 196 99 98 55 47 17 309
Bumjin Lim South Korea 11 123 0.6× 43 0.4× 64 0.7× 51 0.9× 16 0.3× 51 250
T Misaki Japan 10 213 1.1× 48 0.5× 136 1.4× 15 0.3× 20 0.4× 43 337
T.J. Crook United Kingdom 9 100 0.5× 73 0.7× 65 0.7× 35 0.6× 26 0.6× 22 320
C. Bastide France 10 240 1.2× 39 0.4× 89 0.9× 105 1.9× 10 0.2× 57 347
Anand Narayan Singh India 12 201 1.0× 97 1.0× 232 2.4× 35 0.6× 16 0.3× 32 455
M Barbagelatta France 7 166 0.8× 56 0.6× 283 2.9× 12 0.2× 12 0.3× 15 384
Seido Jitsukawa Japan 13 126 0.6× 43 0.4× 162 1.7× 15 0.3× 10 0.2× 40 339
S. Madan United States 9 133 0.7× 58 0.6× 135 1.4× 60 1.1× 26 0.6× 15 369
Fredrik Petersson Singapore 11 118 0.6× 111 1.1× 90 0.9× 17 0.3× 5 0.1× 28 309
Thomas Filbeck Germany 12 148 0.8× 92 0.9× 498 5.1× 17 0.3× 14 0.3× 17 608

Countries citing papers authored by Joseph Mashni

Since Specialization
Citations

This map shows the geographic impact of Joseph Mashni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Mashni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Mashni more than expected).

Fields of papers citing papers by Joseph Mashni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Mashni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Mashni. The network helps show where Joseph Mashni may publish in the future.

Co-authorship network of co-authors of Joseph Mashni

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Mashni. A scholar is included among the top collaborators of Joseph Mashni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Mashni. Joseph Mashni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Laviana, Aaron A., Joseph Mashni, Michael C. Large, et al.. (2022). Biodynamic prediction of neoadjuvant chemotherapy response: Results from a prospective multicenter study of predictive accuracy among muscle-invasive bladder cancer patients. Urologic Oncology Seminars and Original Investigations. 41(6). 295.e9–295.e17. 3 indexed citations
2.
Cushman, Taylor R., Joseph Mashni, Terence Roberts, & Rachit Kumar. (2018). The Impact of a 1-Day Multidisciplinary Prostate Cancer Clinic on Patients’ Choice of Treatment. Journal of the American College of Radiology. 15(12). 1745–1748. 1 indexed citations
3.
Murray, Katie S., Emily Vertosick, Massimiliano Spaliviero, et al.. (2018). Importance of wide re‐resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution. Journal of Surgical Oncology. 117(7). 1464–1468. 8 indexed citations
4.
Srimathveeravalli, Govindarajan, F. Cornélis, Joseph Mashni, et al.. (2016). Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate. SpringerPlus. 5(1). 219–219. 10 indexed citations
5.
Murray, Katie S., Behfar Ehdaie, John E. Musser, et al.. (2016). Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. The Journal of Urology. 196(3). 883–890. 62 indexed citations
6.
Zabor, Emily C., Helena Furberg, Joseph Mashni, et al.. (2015). Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms. Clinical Journal of the American Society of Nephrology. 11(1). 101–107. 27 indexed citations
7.
Mashni, Joseph, Melissa Assel, Alexandra C. Maschino, et al.. (2015). New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors. Urology. 86(6). 1137–1145. 26 indexed citations
8.
Bazzi, Wassim M., Ling Y. Chen, Billy H. Cordon, et al.. (2015). Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. International Urology and Nephrology. 47(9). 1499–1502. 5 indexed citations
9.
Chevinsky, Michael, Alexander Sankin, Andrew Winer, et al.. (2015). Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma. The Journal of Urology. 194(2). 310–315. 35 indexed citations
10.
Murray, Katie S., John E. Musser, Joseph Mashni, et al.. (2015). PD47-08 IRREVERSIBLE ELECTROPORATION (IRE) AS A LOCALIZED TREATMENT FOR PROSTATE CANCER: A REPORT ON SAFETY AND OUTCOMES. The Journal of Urology. 193(4S). 1 indexed citations
11.
Musser, John E., Melissa Assel, Joseph Mashni, Daniel D. Sjoberg, & Paul Russo. (2014). Adult Prostate Sarcoma: The Memorial Sloan Kettering Experience. Urology. 84(3). 624–628. 33 indexed citations
12.
Bochner, Bernard H., Andrew Feifer, Dahlia Sperling, et al.. (2014). Multi-institutional quality care initiative (QCI) to improve the care of patients with invasive bladder cancer (BlCa).. Journal of Clinical Oncology. 32(4_suppl). 298–298. 6 indexed citations
13.
Mashni, Joseph, Guilherme Godoy, Guido Dalbagni, et al.. (2014). Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings. International Urology and Nephrology. 46(9). 1699–1705. 27 indexed citations
14.
Mashni, Joseph, Melissa Assel, Alexandra C. Maschino, et al.. (2013). 1304 NEW CHRONIC KIDNEY DISEASE (CKD) AND OVERALL SURVIVAL AFTER NEPHRECTOMY FOR SMALL RENAL CORTICAL TUMORS. The Journal of Urology. 189(4S). 2 indexed citations
15.
Zhang, Ping L., Joseph Mashni, Venkata Sabbisetti, et al.. (2013). Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. International Urology and Nephrology. 46(2). 379–388. 35 indexed citations
16.
Mashni, Joseph & Kenneth M. Peters. (2010). Potential Use of Pudendal Nerve Stimulation for Voiding Dysfunction. Current Bladder Dysfunction Reports. 5(4). 177–182. 5 indexed citations
17.
Mashni, Joseph, et al.. (1985). Computerized Tomographic Demonstration of Inferior Vena Caval Tumor Thrombus from Renal Angiomyolipoma. The Journal of Urology. 133(5). 836–837. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bumjin Lim Breakdown of academic impact, for papers by T Misaki Breakdown of academic impact, for papers by T.J. Crook Breakdown of academic impact, for papers by C. Bastide Breakdown of academic impact, for papers by Anand Narayan Singh Breakdown of academic impact, for papers by M Barbagelatta Breakdown of academic impact, for papers by Seido Jitsukawa Breakdown of academic impact, for papers by S. Madan Breakdown of academic impact, for papers by Fredrik Petersson Breakdown of academic impact, for papers by Thomas Filbeck
Rankless by CCL
2026